Speciality glass manufacturer Schott has invested €75 million to expand its pharma glass production in India.
The Gujarat-based facility is the company’s manufacturing hub for borosilicate glass tubing, a material that is converted to pharmaceutical containers, such as vials, ampoules, or syringes, to store life-saving drugs.
The expansion contributes to the Indian government’s vision of strengthening India as a global pharmaceutical hub, while also supporting Germany’s commitment to invest in India.
Local government officials, business unit executives, and pharma industry representatives celebrated the start of a new production of Fiolax amber pharmaceutical glass tubing at a celebration ceremony this week.
With this move, manufacturers of drug containment solutions in the region can receive Schott's complete portfolio of pharmaceutical glass tubing produced in India.
Amber glass is used to store light-sensitive medications such as antibiotics or chemotherapeutic agents.
The local production will also improve availability, planning reliability, and cost efficiency for pharmaceutical converters.